Saturday 17 October 2026
Export OPK’s income statement to Excel — free account
OPKO Health, Inc.
OPK Healthcare Diagnostics & Research
OPKO Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $606.9 million, down 14.9% from fiscal 2024. In the quarter to June 2026, revenue grew 4.32%, EPS grew 94.7%, free cash flow grew 46.5% and total debt rose 6.37%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
1.53
0.08
−4.97%
Follow OPK
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 79.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Piotroski F-Score |
5 | 2 | 4 | 2 | 7 | 5 | 1 | 3 | 3 | 4 |
P/S ratio |
4.48 | 2.88 | 1.71 | 0.97 | 1.76 | 1.76 | 0.87 | 1.37 | 1.43 | 1.56 |
Altman Z-Score |
4.57 | 1.67 | 1.05 | (0.12) | 1.78 | 2.75 | (0.07) | (0.07) | (0.23) | (0.42) |
P/FCF ratio |
1,021.88 | 0.00 | 0.00 | 0.00 | 0.00 | 50.11 | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z″-Score (non-manufacturers) |
2.68 | 0.65 | 0.87 | (0.28) | 0.79 | 1.82 | (0.19) | (1.08) | (0.41) | (0.79) |
Beneish M-Score |
(1.91) | (3.04) | (2.72) | (2.94) | (1.71) | (2.63) | (3.37) | (2.97) | (2.33) | (2.81) |
P/Operating CF |
165.22 | 1,317.08 | (48.91) | (19.01) | 73.87 | (552.41) | (27.74) | (30.82) | (22.97) | (36.51) |
P/B ratio |
2.39 | 1.51 | 0.95 | 0.54 | 1.51 | 1.85 | 0.56 | 0.85 | 0.75 | 0.75 |
Price to Tangible BV |
8.03 | 6.28 | 3.56 | 2.12 | 4.90 | 3.70 | 6.17 | 23.29 | 4.65 | 3.54 |
EV/Sales |
4.38 | 2.82 | 1.71 | 1.12 | 1.89 | 1.79 | 0.97 | 1.54 | 1.43 | 1.51 |
EV/EBITDA |
18,694.23 | 0.00 | 0.00 | 0.00 | 18.87 | 32.42 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
152.72 | (29.63) | (15.51) | (5.86) | 68.81 | 83.08 | (10.20) | (47.03) | (5.57) | (5.15) |
EV/FCF |
998.81 | (19.31) | (11.62) | (5.19) | (685.78) | 51.20 | (7.60) | (25.62) | (4.68) | (4.58) |
Quick Ratio |
1.48 | 0.82 | 0.83 | 0.88 | 0.95 | 1.20 | 1.31 | 1.10 | 2.85 | 3.13 |
Current Ratio |
1.84 | 1.12 | 1.10 | 1.30 | 1.39 | 2.49 | 1.85 | 1.55 | 3.43 | 3.97 |
Net Debt/EBITDA |
(431.49) | 0.29 | 0.02 | (0.76) | 1.29 | 0.69 | (0.81) | (2.89) | (0.04) | 1.33 |
Debt/Assets |
2.01% | 1.59% | 3.86% | 9.56% | 10.43% | 8.44% | 11.40% | 12.01% | 19.73% | 17.69% |
Debt/Equity |
0.03 | 0.02 | 0.05 | 0.14 | 0.15 | 0.12 | 0.16 | 0.17 | 0.32 | 0.27 |
Asset Turnover |
0.40 | 0.36 | 0.39 | 0.38 | 0.60 | 0.73 | 0.44 | 0.41 | 0.34 | 0.29 |
Operating CF/Net income |
(0.66) | 0.30 | 0.71 | 0.55 | 1.29 | (1.27) | 0.29 | 0.15 | 3.45 | 0.79 |
Capex/Depreciation |
(0.23) | (0.38) | (0.27) | (0.13) | (0.39) | 0.43 | (0.21) | (0.13) | (0.25) | (0.12) |
Interest Coverage |
(12.99) | (41.88) | (14.40) | (12.74) | 2.63 | 0.99 | (18.77) | (11.63) | (3.20) | (1.08) |
| (2.38%) | (15.51%) | (8.42%) | (18.49%) | 1.86% | (1.80%) | (20.23%) | (12.80%) | (3.86%) | (17.14%) | |
| (1.74%) | (11.40%) | (6.07%) | (13.23%) | 1.28% | (1.24%) | (14.38%) | (9.04%) | (2.53%) | (10.92%) | |
ROIC |
(3.05%) | (9.64%) | (5.98%) | (9.79%) | 1.94% | 0.67% | (8.54%) | (6.39%) | (6.95%) | (5.91%) |
Return on Tangible Assets |
(14.09%) | (166.45%) | (87.91%) | (155.87%) | 10.61% | (5.26%) | (124.43%) | (102.17%) | (9.87%) | (44.33%) |
Average Days of Receivables |
71.95 | 62.54 | 53.04 | 54.48 | 72.80 | 53.40 | 46.27 | 52.15 | 60.40 | 54.28 |
Research and Development Expense of Revenue |
10.19% | 13.09% | 12.68% | 13.07% | 5.25% | 4.33% | 7.36% | 10.38% | 14.75% | 20.44% |
Selling, General and Administrative Expense of Revenue |
36.45% | 42.92% | 36.19% | 38.06% | 24.77% | 26.42% | 37.11% | 34.81% | 42.66% | 36.75% |
Intangible Assets out of Total Assets |
0.53 | 0.54 | 0.54 | 0.52 | 0.47 | 0.35 | 0.65 | 0.67 | 0.52 | 0.52 |
Share Based Compensation of Revenue |
3.82% | 2.93% | 2.20% | 1.49% | 0.62% | 0.77% | 1.84% | 1.32% | 1.55% | 1.77% |
Graham Net Nets |
(0.04) | (0.14) | (0.20) | (0.42) | (0.11) | 0.03 | (0.24) | (0.27) | (0.17) | (0.09) |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 1.71 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
(0.96%) | (11.07%) | (8.97%) | (36.05%) | 1.27% | (1.04%) | (36.07%) | (15.92%) | (5.09%) | (23.81%) |
Free Cash Flow Yield |
0.10% | (5.09%) | (8.60%) | (22.23%) | (0.16%) | 2.00% | (14.57%) | (4.39%) | (21.39%) | (21.19%) |
Revenue per Share |
2.03 | 1.73 | 1.76 | 1.51 | 2.24 | 2.74 | 1.40 | 1.15 | 1.03 | 0.81 |
Operating CF per Share |
0.06 | (0.16) | (0.19) | (0.29) | 0.06 | 0.06 | (0.13) | (0.04) | (0.26) | (0.24) |
Capex per Share |
(0.04) | (0.07) | (0.05) | (0.02) | (0.05) | 0.05 | (0.03) | (0.02) | (0.04) | (0.02) |
Free Cash Flow per Share |
0.02 | (0.23) | (0.24) | (0.31) | 0.01 | 0.11 | (0.16) | (0.06) | (0.30) | (0.25) |
Cash per Share |
0.31 | 0.16 | 0.17 | 0.14 | 0.11 | 0.21 | 0.21 | 0.13 | 0.62 | 0.49 |
Shareholders Equity per Share |
3.80 | 3.30 | 3.18 | 2.71 | 2.61 | 2.60 | 2.17 | 1.85 | 1.97 | 1.69 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
3.80 | 3.30 | 3.18 | 2.71 | 2.61 | 2.60 | 2.17 | 1.85 | 1.97 | 1.69 |
Free Cash Flow |
9.90 | (131.33) | (135.78) | (184.59) | 6.04 | 72.21 | (117.82) | (41.76) | (208.26) | (190.53) |
Working Capital |
220.31 | 36.83 | 29.41 | 74.93 | 147.70 | 493.01 | 181.05 | 109.42 | 468.99 | 435.20 |
Capital Expenditures |
(22.15) | (39.25) | (26.63) | (12.07) | (33.44) | 33.87 | (22.63) | (13.56) | (24.77) | (11.99) |
Net Current Asset Value |
(191.21) | (397.47) | (342.05) | (370.47) | (278.33) | 108.42 | (211.09) | (313.00) | (172.67) | (82.10) |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 47.07 | 169.88 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.02 | 0.04 | 0.03 | 0.01 | 0.02 | (0.02) | 0.02 | 0.02 | 0.03 | 0.02 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 43.85 | 166.25 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.79 | 0.70 | 0.67 | 0.75 | 0.61 | 1.00 | 1.33 | 1.41 | 1.43 | 1.31 |
Cash ROIC |
0.43% | (6.65%) | (6.85%) | (9.61%) | 0.30% | 3.57% | (6.01%) | (2.42%) | (9.33%) | (9.63%) |
Accounts Receivable Turnover |
5.40 | 5.01 | 6.40 | 6.48 | 6.82 | 6.50 | 5.19 | 6.89 | 5.91 | 5.83 |
Accounts Payable Turnover |
9.71 | 9.71 | 9.94 | 10.42 | 4.42 | 5.63 | 9.61 | 7.98 | 8.47 | 9.09 |
Inventory Turnover |
14.07 | 12.84 | 13.20 | 11.96 | 9.63 | 10.90 | 8.92 | 7.80 | 8.08 | 6.54 |
Average Days of Payables |
31.85 | 43.74 | 28.61 | 39.87 | 139.47 | 25.10 | 34.15 | 46.63 | 34.73 | 37.42 |
Days of Inventory on Hand |
28.19 | 29.04 | 25.53 | 34.07 | 54.01 | 26.46 | 37.76 | 43.97 | 41.91 | 59.92 |
Average Receivables |
207.08 | 192.90 | 154.71 | 139.26 | 210.47 | 272.98 | 193.47 | 125.35 | 120.70 | 104.14 |
Average Payables |
62.95 | 63.83 | 60.85 | 54.97 | 202.14 | 211.90 | 74.52 | 68.34 | 58.37 | 44.09 |
Average Inventory |
43.45 | 48.28 | 45.82 | 47.87 | 92.89 | 109.42 | 80.28 | 69.88 | 61.25 | 61.31 |
Average Assets |
2,782.90 | 2,678.29 | 2,520.51 | 2,380.17 | 2,391.17 | 2,436.39 | 2,283.49 | 2,089.48 | 2,105.96 | 2,066.08 |
Average Common Equity |
2,035.80 | 1,967.72 | 1,817.46 | 1,703.03 | 1,643.16 | 1,678.34 | 1,623.39 | 1,475.43 | 1,377.33 | 1,316.70 |
Columns are period end dates